IP Library Granted Patent US 11,427,845
Granted Patent B2
US 11,427,845 · App. 15/067,037 · Granted Aug 30, 2022

Production of oligosaccharides

Inventor: Stefan Jennewein (Bad Honnef, DE)
Assignee: Chr. Hansen HMO GmbH
C12P19/26C07H1/00C07H1/06C12P19/12C12P19/14C12Y302/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,427,845
App. No.
15/067,037
Granted
Aug 30, 2022
Kind
B2
Abstract

The present invention relates to the use of one or more glycosidases in the process for the production and/or purification of a produced desired oligosaccharide. The process is preferably a microbial fermentation process using a host microorganism, which may also comprise nucleic acids expressing sugar catabolic pathway proteins suitable for the degradation of saccharides otherwise hindering the purification of the desired oligosaccharide.

Claims (22)

1. A process for producing a 2′-fucosyllactose in a host microorganism, wherein said 2′-fucosyllactose is not naturally occurring in said host microorganism, the process comprising the steps of:

a) cultivating the host microorganism that produces the 2′-fucosyllactose under conditions and in a fermentation medium suitable for the production of 2′ fucosyllactose, thereby producing 2′ fucosyllactose and undesired biosynthetic saccharide intermediates;

b) directly adding an exogenous beta-galactosidase enzyme to the fermentation medium at the end of the cultivation of a) to degrade unused saccharide substrates and/or undesired biosynthetic saccharide intermediates and/or saccharide side products generated during production of the 2′ fucosyllactose in step a), and

c) recovering the 2′-fucosyllactose.

2. The process of claim 1 , further comprising centrifuging the cultivated host microorganism to obtain a supernatant and a host microorganism pellet, and recovering the 2′-fucosyllactose from the supernatant.

3. The process of claim 1 , wherein the host microorganism is a bacterium or a yeast.

4. The process of claim 3 , wherein the host microorganism is an Escherichia coli strain, Lactobacillus species, a Corynebacterium glutamicum strain or a Saccharomyces sp. strain.

5. The process of claim 1 , wherein the host microorganism overexpresses a salvage pathway for a monosaccharide generated during production of the 2′-fucosyllactose, to convert the monosaccharide into its nucleotide-activated form.

6. The process of claim 1 , wherein the host microorganism is a wild-type microorganism modified to overexpress proteins for a galactose catabolic pathway under the control of an inducible promoter.

7. A method for purifying 2′-fucosyllactose from a mixture containing the 2′-fucosyllactose and

(a) non-desired oligosaccharides or metabolic saccharide products generated during production of said 2′-fucosyllactose, and/or

(b) unused saccharide substrates used in the production of said 2′-fucosyllactose,

the method comprising] adding beta-galactosidase to the mixture to degrade the non-desired oligosaccharides or metabolic saccharide products or unused substrates; and recovering the 2′-fucosyllactose from the mixture.

8. The method of claim 7 , wherein the 2′-fucosyllactose is produced by in vitro oligosaccharide synthesis or by chemical synthesis or by combinations thereof.

9. The method of claim 7 , wherein the 2′-fucosyllactose is a non-naturally occurring oligosaccharide in a host microorganism expressing a beta-galactosidase, and wherein the 2′-fucosyllactose is produced by a microbial fermentation process in the host microorganism.

10. A process for producing 2′-fucosyllactose in a host microorganism, wherein said 2′-fucosyllactose is not naturally occurring in said host microorganism, the process comprising the steps of:

a) cultivating a host microorganism that can produce 2′-fucosyllactose under conditions and in a medium suitable for the production of 2′-fucosyllactose, thereby producing 2′-fucosyllactose and-undesired biosynthetic saccharide intermediates;

b) externally adding a beta-galactosidase to the medium following production of the 2′-fucosyllactose in step a) to degrade unused saccharide substrates and/or undesired biosynthetic saccharide intermediates and/or saccharide side products generated during production of the 2′-fucosyllactose in step a), and

c) recovering the 2′-fucosyllactose;

wherein the unused saccharide substrate is lactose.

11. The method of claim 1 , wherein the host microorganism does not endogenously produce the beta-galactosidase.

12. The method of claim 10 , wherein the host microorganism does not endogenously produce the beta-galactosidase.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 4, 2025
From: CHR. HANSEN HMO GMBH
To: CHR. HANSEN A/S
Reel/Frame 070396/0299 →
CHANGE OF NAME Recorded Apr 6, 2022
From: JENNEWEIN BIOTECHNOLOGIE GMBH
To: CHR. HANSEN HMO GMBH
Reel/Frame 059617/0804 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2016
From: JENNEWEIN, STEFAN
To: JENNEWEIN BIOTECHNOLOGIE GMBH
Reel/Frame 039543/0688 →
Priority Claims (1)
EP 13183670 · Sep 10, 2013 · regional
Continuity (2)
Continuation PCTEP2014064280 · Jul 4, 2014
Related Publication 20160186223A1 · Jun 30, 2016
Cited By (1)
US 12,252,685